PROTALIX BIOTHERAPEUTICS INC's ticker is and the CUSIP is 74365AAD3.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,412,000 | +1.1% | 1,397,000 | 0.0% | 0.08% | +11.3% |
Q2 2021 | $1,397,000 | +2.9% | 1,397,000 | 0.0% | 0.07% | -39.8% |
Q1 2021 | $1,357,000 | +2.7% | 1,397,000 | 0.0% | 0.12% | 0.0% |
Q4 2020 | $1,321,000 | +3.5% | 1,397,000 | 0.0% | 0.12% | -17.5% |
Q3 2020 | $1,276,000 | -51.1% | 1,397,000 | -51.5% | 0.14% | -59.9% |
Q2 2020 | $2,610,000 | +1.8% | 2,879,000 | 0.0% | 0.36% | +86.9% |
Q1 2020 | $2,563,000 | +2.4% | 2,879,000 | 0.0% | 0.19% | -50.5% |
Q4 2019 | $2,502,000 | +9.9% | 2,879,000 | 0.0% | 0.39% | +33.1% |
Q3 2019 | $2,276,000 | -17.3% | 2,879,000 | 0.0% | 0.29% | -7.6% |
Q2 2019 | $2,752,000 | +0.3% | 2,879,000 | 0.0% | 0.31% | +22.2% |
Q1 2019 | $2,743,000 | +0.2% | 2,879,000 | 0.0% | 0.26% | +49.4% |
Q4 2018 | $2,737,000 | +0.1% | 2,879,000 | 0.0% | 0.17% | -20.0% |
Q3 2018 | $2,735,000 | +10.2% | 2,879,000 | 0.0% | 0.22% | +35.2% |
Q2 2018 | $2,482,000 | -9.9% | 2,879,000 | 0.0% | 0.16% | +9.7% |
Q1 2018 | $2,756,000 | -50.4% | 2,879,000 | -50.0% | 0.14% | -5.8% |
Q4 2017 | $5,552,000 | +243.8% | 5,758,000 | +197.1% | 0.15% | +105.3% |
Q3 2017 | $1,615,000 | -26.0% | 1,938,000 | 0.0% | 0.08% | -29.9% |
Q2 2017 | $2,183,000 | -29.5% | 1,938,000 | 0.0% | 0.11% | -43.4% |
Q1 2017 | $3,096,000 | +84.4% | 1,938,000 | 0.0% | 0.19% | +53.7% |
Q4 2016 | $1,679,000 | – | 1,938,000 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 31,014,000 | $29,401,000 | 1.13% |
UBS OCONNOR LLC | 8,000,000 | $7,440,000,000 | 0.15% |
WHITEBOX ADVISORS LLC | 5,000,000 | $4,727,000 | 0.15% |
ANGELO GORDON & CO., L.P. | 1,397,000 | $1,321,000 | 0.12% |
INGALLS & SNYDER LLC | 500,000 | $474,000 | 0.02% |
CITIGROUP INC | 7,832,000 | $7,404,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |